Interpace Biosciences, Inc. (IDXG) Gross profit 2016–2025
Interpace Biosciences, Inc. (IDXG) annual gross profit history from SEC filings — each fiscal year as reported.
$24.1MFY2025 · since FY2016: $6.4M → $24.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $24.1M | -19.4% |
| FY2024 | $29.9M | +19.4% |
| FY2023 | $25.1M | +37.4% |
| FY2022 | $18.2M | -3.0% |
| FY2021 | $18.8M | +75.3% |
| FY2020 | $10.7M | +28.7% |
| FY2019 | $8.3M | -28.8% |
| FY2018 | $11.7M | +37.0% |
| FY2017 | $8.5M | +32.5% |
| FY2016 | $6.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice